University of Pittsburgh Cancer Institute (UPCI)

Satellite Conference Agenda

Wednesday, June 21, 2017

2017 UPCI Satellite Conference
New Therapeutic Strategies in Killing Tumor Cells: Exploiting Genome Instability
Chair: Bennett Van Houten, PhD
Professor of Pharmacology & Chemical Biology; Co-leader, UPCI Molecular and Cellular Cancer Biology Program
Co-Chair: Patricia Opresko, PhD
Associate Professor of Environmental & Occupational Health


3:00 pm - 3:30 pm

Registration / Foyer - Third Floor

3:30 pm - 3:40 pm

Introduction / Ballroom - Third Floor

 

Bennett Van Houten, PhD
Professor of Pharmacology & Chemical Biology

3:40 pm - 5:00 pm

Session I / Ballroom - Third Floor

5:00 pm - 5:15 pm

Break

5:15 pm - 6:35 pm

Session II / Ballroom - Third Floor

6:35 pm - 6:45 pm

Concluding Remarks / Ballroom - Third Floor

Bennett Van Houten, PhD
Professor of Pharmacology & Chemical Biology; Co-leader, UPCI Molecular and Cellular Cancer Biology Program

Patricia Opresko, PhD
Associate Professor of Environmental & Occupational Health

6:45 pm - 8:30 pm

Dinner and Drinks / Ballroom and Foyer - Third Floor




29th Annual UPCI Scientific Retreat Agenda

Thursday, June 22, 2017


7:45 am

Registration Opens / Main Entrance Lobby

7:45 am - 8:30 am

Continental Breakfast / Ballroom and Foyer – Third Floor


Poster Set-up / First Floor Hallway
All posters must be set up by 11:00 am
Removal will be from 7:00 pm to 9:00 pm

8:30 am - 9:30 am

Welcome and Director's Overview / Auditorium – First Floor
Edward Chu, MD
Interim Director, University of Pittsburgh Cancer Institute; Co-leader, UPCI Cancer Therapeutics Program

9:30 am - 11:00 am

Session I: Development of Novel Therapeutics: From Mouse to Man / Auditorium – First Floor

 

Session Co-Chairs:

Kara Bernstein, PhD
Assistant Professor of Microbiology and Molecular Genetics

 

Timothy Burns, MD, PhD
Assistant Professor of Medicine, Division of Hematology/Oncology

 

Trial 1

9:30 am - 9:45 am
ATR Kinase Inhibition Suppresses Immune Checkpoint Activation Following Radiation
Frank Vendetti, PhD
Postdoctoral Associate, Department of Radiation Oncology

 

9:45 am - 10:00 am
ATR Inhibitors in the Clinic (Phase I Trial of VX-970 with Irinotecan)
Liza Villaruz, MD
Assistant Professor of Medicine, Division of Hematology/Oncology

 

10:00 am - 10:10 am
Patient Presentation

 

10:10 am - 10:20 am
Trial 1 Q&A

 

Trial 2

10:20 am - 10:35 am
Development of Autophagy and Checkpoint inhibitors in combination with Gemcitabine plus Abraxane
Herbert Zeh, III, MD, FACS
Professor, Watson Family Chair in Surgery, Division of Surgical Oncology

 

10:35 am - 10:50 am
Clinical Experience with Gemcitabine plus Abraxane and HCQ and Current Plans
Nathan Bahary, MD, PhD
Assistant Professor of Medicine, Division of Hematology/Oncology

 

10:50 am - 11:00 am
Trial 2 Q&A

11:00 am - 11:30 am

Lightning Round I / Auditorium – First Floor
Deborah L. Galson, PhD
Associate Professor of Medicine, and Microbiology & Molecular Genetics; Director, Pittsburgh Center for Bone & Mineral Research

11:30 am - 12:30 pm

Lunch / Ballroom and Foyer – Third Floor

12:30 pm - 2:00 pm

Poster Session I and Poster Judging / First Floor Hallway


Note: All poster presenters assigned to this session should be at their posters for the duration of the session.

2:00 pm - 3:00 pm

Ronald B. Herberman Lectureship Keynote Address /
Auditorium – First Floor
Molecular Insights into Colorectal Cancer Pathogenesis
Eric R. Fearon, MD, PhD

Emanuel N. Maisel Professor of Oncology
Director, University of Michigan Comprehensive Cancer Center
Professor, Departments of Internal Medicine, Pathology and Human Genetics

3:00 pm - 3:15 pm

Break

3:15 pm - 4:45 pm

Session II: Shining New Light on the Fog: Advances in the Science of Neurocognitive Function Across the Disease Trajectory /
Auditorium – First Floor

 

Session Co-Chairs:

Heidi Donovan, PhD, RN
Professor & Vice Chair for Research: School of Nursing, Department of Health & Community Systems

 

Robert Ferguson, PhD
Assistant Professor of Medicine

 

3:15 pm - 3:35 pm
The Genetics of Objective Neuro-cognitive Function Pre-surgery to
Post-chemo/Aromitase Inhibitor Therapy

Yvette Conley, PhD
Professor and Vice Chair for Research: Health Promotion & Development; Professor of Human Genetics

 

3:35 pm - 3:55 pm
Brain Biomarkers of Cognitive and Mood Changes Related to Aromatase Inhibitor Use (K99/R00)
John Merriman, PhD, RN
Postdoctoral Scholar, School of Nursing

 

3:55 pm - 4:15 pm
Influence of Exercise on Neurocognitive Function in Breast Cancer (NCI-funded RCT currently in progress)
Catherine Bender, PhD, RN, FAAN
Professor and Endowed Oncology Chair: School of Nursing, Department of Health & Community Systems

 

4:15 pm - 4:30 pm
Patient Advocate

 

4:30 pm - 4:45 pm
Session Q & A

4:45 pm - 5:00 pm

Break

5:00 pm - 5:30 pm

Lightning Round II / Auditorium – First Floor
Deborah L. Galson, PhD
Associate Professor of Medicine, and Microbiology & Molecular Genetics; Director, Pittsburgh Center for Bone & Mineral Research

5:30 pm - 7:00 pm

Poster Session II and Poster Judging / First Floor Hallway


Note: All poster presenters assigned to this session should be at their posters for the duration of the session. Posters must be removed by 9:00 pm.

7:00 pm - 8:30 pm

Dinner and Drinks / Ballroom and Foyer – Third Floor

Friday, June 23, 2017



8:00 am - 9:00 am

Continental Breakfast / Ballroom and Foyer – Third Floor

9:00 am - 10:00 am

Announcement of Awards / Ballroom – Third Floor

 

9:00 am - 9:15 am
Announcement of Poster Presentation Awards

 

9:15 am - 10:00 am
Announcement of Junior Scholar Awards and Presentations

10:00 am - 11:30 am

Session III: Combinations Enabling Immunotherapeutic Response /
Ballroom – Third Floor

 

Session Chair:

Greg Delgoffe, PhD
Assistant Professor of Immunology

 

10:00 am - 10:25 am
PD-1 in Combination with Other Checkpoints
Diwakar Davar, MBBS, MSc
Assistant Professor of Medicine, Division of Hematology/Oncology

 

10:25 am - 10:50 am
Microenvironment Potentiation with IL-33 and Other Approaches
Binfeng Lu, PhD
Associate Professor of Immunology

 

10:50 am - 11:10 am
Immunotherapy Approaches in Combination with Chemotherapy
Herbert Zeh, III, MD, FACS
Professor, Watson Family Chair in Surgery, Division of Surgical Oncology

 

11:10 am - 11:30 am
Immunotherapy and Radiation
David “Andy” Clump, MD, PhD
Assistant Professor of Radiation Oncology

11:30 am - 12:00 pm

Closing Remarks / Ballroom – Third Floor

Edward Chu, MD
Interim Director, University of Pittsburgh Cancer Institute

12:00 pm - 1:00 pm

Boxed Lunch and Collaborator Discussion /
Ballroom and Foyer – Third Floor